JP2012532739A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012532739A5 JP2012532739A5 JP2012520713A JP2012520713A JP2012532739A5 JP 2012532739 A5 JP2012532739 A5 JP 2012532739A5 JP 2012520713 A JP2012520713 A JP 2012520713A JP 2012520713 A JP2012520713 A JP 2012520713A JP 2012532739 A5 JP2012532739 A5 JP 2012532739A5
- Authority
- JP
- Japan
- Prior art keywords
- body member
- engineered
- nanoparticle body
- processed
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002105 nanoparticle Substances 0.000 claims description 53
- 239000002245 particle Substances 0.000 claims description 52
- 238000005096 rolling process Methods 0.000 claims description 12
- 239000003814 drug Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 229940124597 therapeutic agent Drugs 0.000 claims description 7
- 239000000443 aerosol Substances 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- -1 taggant Substances 0.000 claims description 4
- 239000002872 contrast media Substances 0.000 claims description 3
- 239000000032 diagnostic agent Substances 0.000 claims description 3
- 229940039227 diagnostic agent Drugs 0.000 claims description 3
- 239000003124 biologic agent Substances 0.000 claims description 2
- 210000003169 central nervous system Anatomy 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 239000000696 magnetic material Substances 0.000 claims description 2
- 239000002907 paramagnetic material Substances 0.000 claims description 2
- 238000005191 phase separation Methods 0.000 claims description 2
- 230000002685 pulmonary effect Effects 0.000 claims description 2
- 230000019491 signal transduction Effects 0.000 claims description 2
- 238000000034 method Methods 0.000 description 7
- 239000011344 liquid material Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22513809P | 2009-07-13 | 2009-07-13 | |
| US61/225,138 | 2009-07-13 | ||
| PCT/US2010/041797 WO2011008737A2 (en) | 2009-07-13 | 2010-07-13 | Engineered aerosol particles, and associated methods |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014182213A Division JP6189807B2 (ja) | 2009-07-13 | 2014-09-08 | 工学的に作製されたエアロゾル粒子、およびそれに関連した方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012532739A JP2012532739A (ja) | 2012-12-20 |
| JP2012532739A5 true JP2012532739A5 (enExample) | 2013-08-15 |
| JP5656996B2 JP5656996B2 (ja) | 2015-01-21 |
Family
ID=42818752
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012520713A Expired - Fee Related JP5656996B2 (ja) | 2009-07-13 | 2010-07-13 | 工学的に作製されたエアロゾル粒子、およびそれに関連した方法 |
| JP2014182213A Active JP6189807B2 (ja) | 2009-07-13 | 2014-09-08 | 工学的に作製されたエアロゾル粒子、およびそれに関連した方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014182213A Active JP6189807B2 (ja) | 2009-07-13 | 2014-09-08 | 工学的に作製されたエアロゾル粒子、およびそれに関連した方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20120114554A1 (enExample) |
| EP (1) | EP2454011A2 (enExample) |
| JP (2) | JP5656996B2 (enExample) |
| WO (1) | WO2011008737A2 (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9057712B1 (en) | 2011-10-27 | 2015-06-16 | Copilot Ventures Fund Iii Llc | Methods of delivery of encapsulated perfluorocarbon taggants |
| WO2013082111A2 (en) * | 2011-11-29 | 2013-06-06 | The University Of North Carolina At Chapel Hill | Geometrically engineered particles and methods for modulating macrophage or immune responses |
| US11505648B2 (en) * | 2015-04-21 | 2022-11-22 | Ran Biotechnologies, Inc. | Fluorinated surfactants |
| UY36851A (es) | 2015-08-16 | 2017-03-31 | Glaxosmithkline Ip Dev Ltd | Compuestos para uso en aplicaciones antibacterianas |
| AR106018A1 (es) | 2015-08-26 | 2017-12-06 | Achillion Pharmaceuticals Inc | Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos |
| EP3340982B1 (en) | 2015-08-26 | 2021-12-15 | Achillion Pharmaceuticals, Inc. | Compounds for treatment of immune and inflammatory disorders |
| BR112018009899A8 (pt) | 2015-11-18 | 2019-02-26 | Glaxosmithkline Ip No 2 Ltd | composição, inalador, forma de dosagem única, métodos para fabricar partículas, para melhorar as exacerbações induzidas por infecção respiratória de um distúrbio respiratório, para prevenir as exacerbações induzidas por infecção respiratória de um distúrbio respiratório, para reduzir a incidência das exacerbações induzidas por infecção respiratória de um distúrbio respiratório, para reduzir a gravidade das exacerbações induzidas por infecção respiratória de um distúrbio respiratório, para prevenir uma infecção respiratória viral e para fabricar uma partícula de inalação de pó seco de ribavirina controlada na forma polimorfa cristalina, partículas fabricadas, método de tratamento, pluralidade de partículas, e, recipiente de dose. |
| CN105790924B (zh) * | 2016-04-28 | 2018-11-02 | 滁州博明信息科技有限公司 | 一种具有Lorenz型吸引子的简单混沌系统电路 |
| IL262720B2 (en) | 2016-05-05 | 2024-06-01 | Liquidia Tech Inc | Dry powder treprostinil for the treatment of pulmonary hypertension |
| EP3455219A4 (en) | 2016-05-10 | 2019-12-18 | C4 Therapeutics, Inc. | AMINE-RELATED C3-GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN REDUCTION |
| AU2017290593A1 (en) | 2016-06-27 | 2019-01-03 | Achillion Pharmaceuticals, Inc. | Quinazoline and indole compounds to treat medical disorders |
| CN110603252A (zh) | 2017-03-01 | 2019-12-20 | 艾其林医药公司 | 用于治疗医学障碍的芳基、杂芳基和杂环药物化合物 |
| CN118440096A (zh) | 2017-06-20 | 2024-08-06 | C4医药公司 | 用于蛋白降解的n/o-连接的降解决定子和降解决定子体 |
| KR20210018199A (ko) | 2018-03-26 | 2021-02-17 | 씨4 테라퓨틱스, 인코포레이티드 | 이카로스의 분해를 위한 세레블론 결합제 |
| WO2020041301A1 (en) | 2018-08-20 | 2020-02-27 | Achillion Pharmaceuticals, Inc. | Pharmaceutical compounds for the treatment of complement factor d medical disorders |
| US11814391B2 (en) | 2018-09-06 | 2023-11-14 | Achillion Pharmaceuticals, Inc. | Macrocyclic compounds for the treatment of medical disorders |
| WO2020081723A1 (en) | 2018-10-16 | 2020-04-23 | Georgia State University Research Foundation, Inc. | Carbon monoxide prodrugs for the treatment of medical disorders |
| US20250197403A1 (en) | 2020-02-20 | 2025-06-19 | Achillion Pharmaceuticals, Inc. | Heteroaryl compounds for treatment of complement factor d mediated disorders |
| AU2021231898A1 (en) | 2020-03-05 | 2022-10-27 | C4 Therapeutics, Inc. | Compounds for targeted degradation of BRD9 |
| CN116437913A (zh) | 2020-09-23 | 2023-07-14 | 艾其林医药公司 | 用于治疗补体介导的病症的药物化合物 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5399363A (en) | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
| AU6130594A (en) | 1991-03-05 | 1994-08-15 | Miris Medical Corporation | Method and device for correcting the drift offset of a pressure sensor of a flowmeter |
| CA2112674C (en) | 1991-07-02 | 2005-10-04 | John S. Patton | Method and device for delivering aerosolized medicaments |
| US5785049A (en) | 1994-09-21 | 1998-07-28 | Inhale Therapeutic Systems | Method and apparatus for dispersion of dry powder medicaments |
| US5934272A (en) | 1993-01-29 | 1999-08-10 | Aradigm Corporation | Device and method of creating aerosolized mist of respiratory drug |
| US5558085A (en) | 1993-01-29 | 1996-09-24 | Aradigm Corporation | Intrapulmonary delivery of peptide drugs |
| US5497763A (en) | 1993-05-21 | 1996-03-12 | Aradigm Corporation | Disposable package for intrapulmonary delivery of aerosolized formulations |
| CZ289029B6 (cs) | 1994-09-21 | 2001-10-17 | Inhale Therapeutic Systems | Způsob aerosolizace práąku, zejména práąkového léku a zařízení k provádění tohoto způsobu |
| US5780014A (en) | 1995-04-14 | 1998-07-14 | Inhale Therapeutic Systems | Method and apparatus for pulmonary administration of dry powder alpha 1-antitrypsin |
| US7704684B2 (en) * | 2003-12-01 | 2010-04-27 | The Board Of Trustees Of The University Of Illinois | Methods and devices for fabricating three-dimensional nanoscale structures |
| KR101281775B1 (ko) | 2003-12-19 | 2013-07-15 | 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 | 소프트 또는 임프린트 리소그래피를 이용하여 분리된마이크로- 및 나노- 구조를 제작하는 방법 |
| WO2007030698A2 (en) * | 2005-09-07 | 2007-03-15 | The University Of North Carolina At Chapel Hill | Materials and methods for fabricating isolated micro-and nano-structures having chemical functionality |
| WO2006130943A1 (en) * | 2005-06-10 | 2006-12-14 | The Governors Of The University Of Alberta | Respirable dried powder formulation comprising drug loaded nanoparticles |
| AU2006282042B2 (en) * | 2005-06-17 | 2011-12-22 | The University Of North Carolina At Chapel Hill | Nanoparticle fabrication methods, systems, and materials |
| EP1951202A4 (en) * | 2005-11-07 | 2013-03-06 | Univ North Carolina | ISOLATED AND SOLID MICRO AND NANO STRUCTURES AND METHOD THEREFOR |
| WO2008011051A1 (en) * | 2006-07-17 | 2008-01-24 | Liquidia Technologies, Inc. | Nanoparticle fabrication methods, systems, and materials |
| US20100055459A1 (en) * | 2006-08-30 | 2010-03-04 | Liquidia Technologies, Inc. | Nanoparticles Having Functional Additives for Self and Directed Assembly and Methods of Fabricating Same |
| US7875654B2 (en) * | 2007-03-23 | 2011-01-25 | The Board Of Trustees Of The University Of Illinois | System for forming janus particles |
-
2010
- 2010-07-13 WO PCT/US2010/041797 patent/WO2011008737A2/en not_active Ceased
- 2010-07-13 EP EP10742329A patent/EP2454011A2/en not_active Ceased
- 2010-07-13 JP JP2012520713A patent/JP5656996B2/ja not_active Expired - Fee Related
- 2010-07-13 US US13/383,518 patent/US20120114554A1/en not_active Abandoned
-
2014
- 2014-09-08 JP JP2014182213A patent/JP6189807B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012532739A5 (enExample) | ||
| JP6189807B2 (ja) | 工学的に作製されたエアロゾル粒子、およびそれに関連した方法 | |
| Cojocaru et al. | Nanoparticle-based drug delivery systems in inhaled therapy: improving respiratory medicine | |
| Heng et al. | The nano spray dryer B-90 | |
| Paris et al. | Mesoporous silica nanoparticles for co-delivery of drugs and nucleic acids in oncology: A review | |
| Zhang et al. | Formation, characterization, and fate of inhaled drug nanoparticles | |
| Kumar et al. | Nanomedicine in drug delivery | |
| CN101479051B (zh) | 生产多层粒子、纤维和喷雾的系统和方法以及施用它们的方法 | |
| Mathaes et al. | Non-spherical micro-and nanoparticles: fabrication, characterization and drug delivery applications | |
| Kan et al. | Airway epithelial-targeted nanoparticles for asthma therapy | |
| Peng et al. | Nano-formulations for pulmonary delivery: Past, present, and future perspectives | |
| Tong et al. | Discrete modelling of powder dispersion in dry powder inhalers-a brief review | |
| Garello et al. | Micro/nanosystems for magnetic targeted delivery of bioagents | |
| Dua et al. | Targeting microRNAs using nanotechnology in pulmonary diseases. | |
| Tomoda et al. | Preparation and properties of inhalable nanocomposite particles: effects of the temperature at a spray-dryer inlet upon the properties of particles | |
| Alagusundaram et al. | Dry powder inhalers-an overview | |
| Negi et al. | Engineering inhalable therapeutic particles: conventional and emerging approaches | |
| Du et al. | Breath and beyond: advances in nanomedicine for oral and intranasal aerosol drug delivery | |
| CN102365126B (zh) | 用于生产包覆粒子的工艺和设备 | |
| Pawara et al. | Spray dried nanoparticle for pulmonary delivery: current developments and future perspectives | |
| Donovan et al. | Novel dry powder inhaler particle-dispersion systems | |
| CN104116712B (zh) | 一种用于肺部给药的干扰素‑白蛋白中空性纳米聚集颗粒 | |
| WO2018150593A1 (ja) | 吸入装置 | |
| US20160030346A1 (en) | Engineered aerosol particles, and associated methods | |
| Kwak et al. | Microfluidic Platforms for Ex Vivo and In Vivo Gene Therapy |